Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?

26 Citationer (Scopus)

Abstract

One reason for the inadequacy of current renoprotective therapy and the persistent poor renal prognosis in diabetic nephropathy is the large interindividual variation in response to treatment. Genetic as well as non-genetic factors are known to influence treatment efficacy. This Commentary summarizes the impact of the angiotensin-converting enzyme (ACE) insertion/deletion polymorphism in the ACE gene on initiation and progression of diabetic nephropathy.

OriginalsprogEngelsk
TidsskriftKidney International
Vol/bind69
Udgave nummer8
Sider (fra-til)1293-5
Antal sider3
ISSN0085-2538
DOI
StatusUdgivet - apr. 2006
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?'. Sammen danner de et unikt fingeraftryk.

Citationsformater